UPF
14.9.2021 19:12:12 CEST | Business Wire | Press release
World leaders and experts renewed their calls for peaceful reconciliation on the Korean Peninsula during the virtual Rally of Hope September 12 (KST). The event, broadcasted live from South Korea and attended by millions of online participants from around the world, featured the Universal Peace Federation’s (UPF) new initiative, Think Tank 2022 , which seeks to build a global strategy for a major breakthrough for peace by the end of 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210914005985/en/
“I truly believe that an extraordinary future awaits the people of North Korea — and I have faith that if they pursue the path of denuclearization, they will make that future a magnificent reality,” former U.S. President Donald Trump said in remarks prepared for the event. “Until that blessed day comes, the indispensable force for peace on the Korean Peninsula remains a strong America. As we have seen recently in other parts of the world, weakness only invites more violence and chaos.”
The rally, the seventh such event since August 2020, is among the growing efforts of UPF Co-Founder Dr. Hak Ja Han Moon to address worldwide challenges, including poverty, equality, and environmental degradation, as well as the peaceful reunification of the Korean Peninsula. “Now the time has come for Korea to fulfill its responsibility,” Dr. Moon said at the event. “[T]he prospects for peace on the Korean Peninsula are excellent. This will happen.”
Dr. Moon and her late husband, the Rev. Dr. Sun Myung Moon, are both natives of what is now North Korea and dedicated their lives toward reunifying their homeland and building a more peaceful world. The online rally, which was live-streamed in the U.S. on September 11, included a solemn prayer engaging the global audience in honor of the thousands of lives lost in the 2001 terror attacks.
Other rally speakers included Samdech Hun Sen , prime minister of Cambodia; José Manuel Barroso , former president of the European Commission; Gloria Macapagal Arroyo , former president of The Philippines; H.D. Deve Gowda , former Indian prime minister; Anthony Thomas Aquinas Carmona , former president of Trinidad and Tobago; and Nataša Mićić , former Serbian president.
“As a country placing priceless value upon peace, Cambodia highly appreciates the organization of this rally to strengthen the culture of peace and mutual trust under the framework of international cooperation in the Asia-Pacific area,” said Prime Minister Sen , whose Asian Vision Institute will serve as the Asia-Pacific Secretariat of Think Tank 2022 . He recalled when Phnom Penh was captured by the Khmer Rouge in 1975 during the Cambodian Civil War, saying, “We remember the tragedy and are determined to prevent such a similar event from happening again... We vividly understand that peace and nation-building can only be achieved by the local stakeholders in the conflicting country.”
Four governors of South Korean provinces, as well as newly elected Seoul Mayor Oh See-hoon , Gwangju Mayor Lee Yong-sup , and Busan Mayor Park Heong-joon , congratulated Dr. Moon and UPF for the work to advance reconciliation and cooperation on the peninsula. Mr. Barroso , speaking from his longtime experience leading the European Commission, said he strongly supports Korean reunification. “What the global community can do, and I believe it should do even more, is to show strong support to facilitate [and] create the best external conditions for the Koreans themselves to find a way for true reconciliation and peace,” he said.
In her remarks, Mrs. Arroyo said, “With leaders Kim Jong-un and Moon Jae-in exchanging letters since April and announcing the restoration of several communication channels in July — including a military link demolished by the North last year — let Korea’s example teach the world that peace can thrive if humanity can dream together.”
Mr. Carmona said, “Collaborative goodwill is the engine of any successful peace process. Reunification and reconciliation require genuine maturity rather than filibustering, a meeting of the minds and hearts, celebrating the common good — not revisiting the painful past, but rather connecting to the intergenerational and intragenerational hope, ambition, and vision of a united Korean people.”
Think Tank 2022 , which is developing Expert Working Groups (EWGs) linked to UPF’s seven international associations, will spearhead peacebuilding projects such as a UN Peace Park on the DMZ, building a Korea-Japan undersea tunnel, boosting Geumgang Mountain tourism development, helping separated Korean families find their relatives, and a call for the UN to establish an office in Korea. Think Tank 2022 has already hosted numerous webinars and will also carry out fact-finding consultations, international leadership conferences, and a major World Summit in South Korea implementing a “One Million People's Relief Association.”
The work of UPF globally aims at promoting constructive dialogue among leaders from all sectors and with diversity of political, philosophical and ideological points of view. In a world characterized too often by polarization and an unwillingness to respectfully engage with those who represent “the other side,” UPF seeks to foster a wider dialogue — a political ecumenism that breaks down barriers and charts a path to mutual respect and understanding. Nowhere is such an approach more desperately needed than that of the Korean Peninsula. For this reason, UPF is engaging with leaders of nations and political parties that are allied with both North and South Korea and are guided by principles of respect, civility, and a commitment to reconciliation.
For additional information about Think Tank 2022 , please click Here
View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005985/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
